Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Allylic Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover advanced Pd-catalyzed synthesis for chiral beta-lactams. High enantioselectivity and scalable processes for reliable pharmaceutical intermediates supply chains.
Patent CN107501266A details a novel Pd-catalyzed asymmetric allylic amination route for high-purity nucleoside intermediates, offering significant supply chain and cost advantages.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.